ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Direct Plan

  • Previous Nav

  • Net Change on 27-02-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option 7.24 19.23 64.29 22.34 26.69 23.16
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI 8.35 20.16 64.72 20.36 21.93 15.53

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 64.29 22.34 26.69 1.05 3,566.52
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 62.01 22.46 24.93 0.97 6,891.31
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 61.94 22.91 25.94 0.98 2,431.44
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 59.73 22.40 29.06 0.64 2,178.77
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 56.37 21.47 26.98 0.52 2,161.17
UTI Healthcare Fund - Direct Plan - Growth Option Jan 01, 2013 58.64 20.09 23.58 1.34 919.33

Fund Holdings as on 31-January-2024

  • Sun Pharmaceutical Industries Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Cipla Ltd.

  • Lupin Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Aurobindo Pharma Ltd.

  • Mankind Pharma Ltd

  • Fortis Healthcare Ltd.

  • Alkem Laboratories Ltd.

  • Zydus Lifesciences Ltd.

  • Biocon Ltd.

  • FDC Ltd.

  • Syngene International Ltd.

  • Krsnaa Diagnostics Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Divi's Laboratories Ltd.

  • Vijaya Diagnostic Centre Pvt Ltd.

  • Aster DM Healthcare Ltd.

  • AMI Organics Ltd.

  • Glaxosmithkline Pharmaceuticals Ltd.

  • Thyrocare Technologies Ltd.

  • Viatris Inc.

  • Shilpa Medicare Ltd.

  • Windlas Biotech Ltd.

  • IPCA Laboratories Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • SBI Life Insurance Company Ltd.

  • HDFC Life Insurance Company Ltd.

  • Blue Jet Healthcare Ltd.

  • Dishman Carbogen Amcis Ltd.

  • Yatharth Hospital & Trauma Care Services Pvt Ltd

  • Piramal Pharma Ltd.

  • Healthcare Global Enterprises Ltd.

  • Laxmi Organic Industries Ltd.

  • Advanced Enzyme Technologies Ltd.

  • TREPS

  • Eris Lifesciences Ltd.

  • Metropolis Healthcare Ltd.

  • 91 Days Treasury Bills

  • Net Current Assets

  • Innova Captab Ltd

  • 364 Days Treasury Bills

  • 182 Days Treasury Bills

  • Cash Margin - Derivatives

  • Indoco Remedies Ltd.

  • Dr. Reddy's Laboratories Ltd. (Covered call) $$

  • Cipla Ltd. (Covered call) $$

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Insurance

  • Miscellaneous

  • Chemicals

View More

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

Scheme Analysis

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹3,566.52 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended up ₹0.12(0.37%)yesterday to ₹32.42.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100